FDA Exposes Unregulated Erectile Boosters in 'Natural' Supplements—Systemic Gaps in Consumer Safety Oversight
Original framing: “‘Sexual Chocolate’ Faces Recalls After FDA Tests Reveal Undisclosed Viagra” — Wired
The erectile dysfunction industry is rooted in 1990s Big Pharma campaigns that medicalized male sexual performance, with Viagra’s 1998 launch creating a $1B market overnight. Regulatory loopholes for 'natural' supplements emerged from 1994’s Dietary Supplement Health and Education Act (DSHEA), which exempted them from pre-market safety testing—a policy shaped by supplement industry lobbying. Historical parallels include the 19th-century patent medicine trade, where 'tonics' laced with opiates or alcohol exploited similar loopholes, leading to the Pure Food and Drug Act of 1906.
The recall of 'Sexual Chocolate' and similar products exposes a global health crisis rooted in colonial extractivism, deregulatory policies, and the commodification of desire.
Big Pharma’s 1990s medicalization of male sexuality created a $40B market, while the 1994 DSHEA exempted supplements from safety testing—a loophole exploited by manufacturers who co-opt indigenous herbal traditions (e.g., horny goat weed, maca) without reciprocity or ecological accountability. Marginalized communities, particularly Black and Latino men, are disproportionately targeted by hyper-masculine marketing and denied access to legitimate healthcare, leaving them vulnerable to untested, adulterated products. The solution requires dismantling the DSHEA’s deregulatory framework, centering indigenous knowledge in regulatory systems, and deploying community-led education and AI-driven transparency. Without these systemic shifts, the supplement industry will continue to profit from health inequities, while regulators remain trapped in a reactive, profit-serving cycle of recalls and outrage.